Trial started· ClinicalTrials.gov
Oral Gallium Maltolate for Recurrent Glioblastoma
Gallium maltolate History and Updates
11 events · 2005 – present
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
0
FDA Approvals
0
Label Revisions
11
Trial Milestones
0
Pivotal Publications
Source: openFDA, ClinicalTrials.gov via AACT, PubMed · Hipa.ai, 2026-05-08Download chart as PNG
This page tracks every FDA action, clinical trial milestone, and major publication for Gallium maltolate since 2005, drawn from openFDA, ClinicalTrials.gov, and PubMed.
Upcoming & expected milestones
Primary completion· ClinicalTrials.gov
Oral Gallium Maltolate for Recurrent Glioblastoma
Primary completion· ClinicalTrials.gov
Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhab
Past events
2026
Trial started· ClinicalTrials.gov
Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhab
Trial registered· ClinicalTrials.gov
Oral Gallium Maltolate for Recurrent Glioblastoma
Trial registered· ClinicalTrials.gov
Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhab
2025
Primary completion· ClinicalTrials.gov
Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
2024
Trial registered· ClinicalTrials.gov
Expanded Access to Gallium Maltolate (GaM)
2022
Trial started· ClinicalTrials.gov
Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
2020
Trial registered· ClinicalTrials.gov
Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
2005
Primary completion· ClinicalTrials.gov
Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies
Sources
FDA approvals, label revisions, and recalls come from the public openFDA APIs (Drugs@FDA, Drug Label, Drug Enforcement). Drug-safety communications come from the FDA RSS feed. Trial milestones come from ClinicalTrials.gov via the AACT pg dump. Pivotal-publication events come from PubMed, filtered to high-impact journals linked to a Phase 3 trial in our inventory.